Investor Relations

This section of the Co-Diagnostics InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Co-Diagnosticsassumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQCODX
Beta(1.87)
Shares Outstanding28.9M
Average Volume (10 days)610.6K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)$1.42
Sales (TTM)$3.62
Book Value (MRQ)$3.47
Cash Flow (TTM)$1.89
Cash (MRQ)$2.90

Analyst Views

Current Mean RecommendationBuy
Strong Buy2
 
Buy0
 
Hold1
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Brian L. Brown
Chief Financial Officer
21,667
Acquire
Nov 23, 2021
Brian L. Brown
Chief Financial Officer
(6,684)
Dispose
Nov 23, 2021
Dwight H Egan
Director, Chief Executive Officer
33,333
Acquire
Nov 23, 2021
Dwight H Egan
Director, Chief Executive Officer
(15,544)
Dispose
Nov 23, 2021
Eugene Durenard
Director
(2,000)
Sell
Sep 8, 2021

Recent SEC Filings

Insider Buy/Sell
Nov 24, 2021
Insider Buy/Sell
Nov 24, 2021
Company Events
Nov 12, 2021
Quarterly Financials
Nov 12, 2021
Insider Buy/Sell
Sep 22, 2021